Alnylam Pharmaceuticals shares owned by Natixis Asset Management Advisors
Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Natixis Asset Management Advisors
from 13F filings
Historical chart of Natixis Asset Management Advisors investment in Alnylam Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals held by Natixis Asset Management Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Alnylam Pharmaceuticals by Natixis Asset Management Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $26M | 78k | 330.87 |
| 2025-12-31 | $18M | 44k | 397.65 |
| 2025-09-30 | $9.9M | 22k | 456.00 |
| 2025-06-30 | $3.3M | 10k | 326.05 |
| 2024-12-31 | $2.5M | 11k | 235.34 |
| 2024-09-30 | $2.8M | 10k | 275.05 |
| 2022-03-31 | $1.7M | 10k | 163.34 |
| 2021-12-31 | $2.1M | 13k | 169.61 |
| 2021-09-30 | $3.7M | 20k | 188.80 |
| 2021-06-30 | $1.9M | 11k | 169.52 |
More positions owned by Natixis Asset Management Advisors
View all positions for Natixis Asset Management Advisors